Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Consolidated Financial Results
for the Three Months Ended February 28, 2025
[Japanese GAAP]
April 11, 2025 | |||||||||||||||||||
Company name: OSAKA ORGANIC CHEMICAL INDUSTRY LTD. | |||||||||||||||||||
Listing: Tokyo Stock Exchange | |||||||||||||||||||
Securities code: 4187 | |||||||||||||||||||
URL: https://www.ooc.co.jp/ | |||||||||||||||||||
Representative: Masayuki Ando | Representative Director and CEO | ||||||||||||||||||
Inquiries: Soichi Honda | Director, Corporate Officer, General Manager of Administration | ||||||||||||||||||
Division | |||||||||||||||||||
Telephone: +81-6-6264-5071 | |||||||||||||||||||
Scheduled date to commence dividend payments: - | |||||||||||||||||||
Preparation of supplementary material on financial results: Yes | |||||||||||||||||||
Holding of financial results briefing: None | |||||||||||||||||||
(Yen amounts are rounded down to millions, unless otherwise noted.) | |||||||||||||||||||
1. Consolidated Financial Results for the Three Months Ended February 28, 2025 (December 1, 2024 to February 28, 2025) | |||||||||||||||||||
(1) Consolidated Operating Results | (Percentages indicate year-on-year changes.) | ||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | ||||||||||||||||
owners of parent | |||||||||||||||||||
Three months ended | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||||||||
February 28, 2025 | 8,516 | 20.5 | 1,365 | 135.2 | 1,480 | 131.3 | 1,035 | 71.6 | |||||||||||
February 29, 2024 | 7,066 | 2.8 | 580 | (42.3) | 640 | (38.4) | 603 | (17.0) | |||||||||||
(Note) Comprehensive income: | Three months ended February 28, 2025: | ¥ | 835 million | [ | (28.3) %] | ||||||||||||||
Three months ended February 29, 2024: | ¥ | 1,164 million | [ | 24.4%] | |||||||||||||||
Basic earnings | Diluted earnings per | ||||||||||||||||||
per share | share | ||||||||||||||||||
Three months ended | Yen | Yen | |||||||||||||||||
February 28, 2025 | 49.96 | - | |||||||||||||||||
February 29, 2024 | 28.47 | - | |||||||||||||||||
(2) Consolidated Financial Position | |||||||||||||||||||
Total assets | Net assets | Capital adequacy ratio | |||||||||||||||||
As of | Millions of yen | Millions of yen | % | ||||||||||||||||
February 28, 2025 | 54,467 | 44,003 | 79.4 | ||||||||||||||||
November 30, 2024 | 59,964 | 46,139 | 75.8 | ||||||||||||||||
(Reference) Equity: As of | February 28, 2025: | ¥ | 43,273 million | ||||||||||||||||
As of | November 30, 2024: | ¥ | 45,435 million |
2. Dividends
Annual dividends | ||||||||
1st | 2nd | 3rd | Year-end | Total | ||||
quarter-end | quarter-end | quarter-end | ||||||
Yen | Yen | Yen | Yen | Yen | ||||
Fiscal year ended November 30, 2024 | - | 32.00 | - | 34.00 | 66.00 | |||
Fiscal year ending November 30, 2025 | - | |||||||
Fiscal year ending November 30, 2025 | 34.00 | - | 34.00 | 68.00 | ||||
(Forecast) | ||||||||
(Note) Revision to the forecast for dividends announced most recently: | None | |||||||
(Note) Breakdown of the 1st quarter dividend for the fiscal year ending November 30, 2025 : | ||||||||
Commemorative dividend | - | yen | ||||||
Special dividend | - | yen |
3. Consolidated Financial Results Forecast for the Fiscal Year Ending November 30, 2025(December 1, 2024 to November 30, 2025) (Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable | Basic earnings | ||||||||
to owners of parent | per share | |||||||||||
Millions of | % | Millions of | % | Millions of | % | Millions of | % | Yen | ||||
yen | yen | yen | yen | |||||||||
Six months ending May | ||||||||||||
16,800 | 9.5 | 2,500 | 34.4 | 2,600 | 30.7 | 1,700 | (15.8) | 81.00 | ||||
31, 2025 | ||||||||||||
Full year | 34,000 | 4.0 | 5,000 | 8.5 | 5,200 | 9.4 | 3,500 | (13.5) | 165.50 | |||
(Note) Revision to the financial results forecast announced most recently: | None | |||||||||||
* Notes: | ||||||||||||
(1) Significant changes in the scope of consolidation during the period: | Yes | |||||||||||
Newly included: | 1 | (Company name: OSAKA ORGANIC CHEMICAL INDUSTRY KOREA LTD. | ) | |||||||||
Excluded: | - | (Company name: - | ) |
- Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None
- Changes in accounting policies, changes in accounting estimates, and restatement
- Changes in accounting policies due to revisions to accounting standards and other regulations: Yes
- Changes in accounting policies due to other reasons: None
- Changes in accounting estimates: None
- Restatement: None
(Note) Please refer to "2. Quarterly Consolidated Financial Statements and Notes, (3) Notes to Quarterly Consolidated Financial Statements, Changes in Accounting Policies" on page 8 of the attached materials for details.
- Number of issued shares (common shares)
- Total number of issued shares at the end of the period (including treasury shares):
February 28, 2025: | 22,410,038 | shares |
November 30, 2024: | 22,410,038 | shares |
2) Number of treasury shares at the end of the period: | ||
February 28, 2025: | 2,083,311 | shares |
November 30, 2024: | 1,283,303 | shares |
3) Average number of shares outstanding during the period: | ||
Three months ended February 28, 2025: | 20,726,729 | shares |
Three months ended February 29, 2024: | 21,195,658 | shares |
- Review of the Japanese-language originals of the attached quarterly consolidated financial statements by certified public accountants or an audit firm: None
- Proper use of earnings forecasts, and other special matters
The forward-looking statements in this document, including forecasts of financial results, are based on information currently available to the Company and are subject to a number of uncertainties. Accordingly, actual results may differ from the forecasts due to changes in business conditions and other factors. Please refer to "Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements" on page 3 of the attached materials for matters related to forecasts of financial results.
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
- Contents of Attachments
1. Overview of Results of Operations | 2 | |
(1) | Results of Operations for the Period under Review | 2 |
(2) | Financial Position for the Period under Review | 3 |
(3) | Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements | 3 |
2. Quarterly Consolidated Financial Statements and Notes | 4 | |
(1) | Quarterly Consolidated Balance Sheets | 4 |
(2) | Quarterly Consolidated Statements of Income and Comprehensive Income | 6 |
(3) | Notes to Quarterly Consolidated Financial Statements | 8 |
Going Concern Assumption | 8 | |
Notes to Quarterly Consolidated Statements of Cash Flows | 8 | |
Significant Changes in Shareholders' Equity | 8 | |
Changes in Scope of Consolidation or Scope of Application of Equity Method | 8 | |
Changes in Accounting Policies | 8 | |
Segment and Other Information | 9 | |
Significant Subsequent Events | 10 |
1
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
1. Overview of Results of Operations
(1) Results of Operations for the Period under Review
During the three months ended February 28, 2025, the Japanese economy continued to recover moderately on the back of personal consumption and capital investment picking up. However, the outlook remains uncertain due to a risk of downward pressure on the Japanese economy stemming from price increases, trade and other policy trends in the U.S., and conditions surrounding the Middle East region.
Under these circumstances, we launched a new medium-term management plan Progress & Development 2030 (P&D 2030) for the period from the fiscal year ended November 30, 2024 to the fiscal year ending November 30, 2030. Based on our Group management philosophy, P&D 2030 has set a management vision of "providing value to the global market as a leading company in specialty acrylic acid esters." Under this vision, we will promote sustainable management that takes ESG into account, aiming to increase corporate value and achieve sustainable growth.
In the Chemical Products Business, we worked to improve profit ratios mainly by integrating and closing products and improving production efficiency, and focused on expanding sales of environmentally friendly products, such as those derived from biomass. In the Electronics Materials Business, the Group worked to accelerate the development of cutting-edge semiconductor materials and to develop new applications for photoresist materials. In the Specialty Chemicals Business, the Group worked to strengthen the overseas expansion of cosmetic raw materials and expand sales of high-purity special solvents. In the current fiscal year, following a subsidiary in South Korea established last year, we are planning to establish a sales base in North America, and we will work to strengthen our overseas sales system by acquiring new customers and cultivating new markets.
As a result, for the three months ended February 28, 2025, net sales were 8,516 million yen (up 20.5% year on year), operating profit was 1,365 million yen (up 135.2% year on year), ordinary profit was 1,480 million yen (up 131.3% year on year), and profit attributable to owners of parent was 1,035 million yen (up 71.6% year on year).
1)Business results by segment are explained below (excluding inter-segment transactions). Chemical Products Business
In the Chemical Products Business, sales of automotive coatings were flat in the acrylic acid ester group, but sales for display adhesives increased significantly, along with increased sales for UV inkjet inks. In the methacrylate ester group, sales were weak. As a result, net sales were 3,316 million yen (up 22.7% year on year) and segment profit was 527 million yen (up 102.4% year on year).
- Electronic Materials Business
In the Electronic Materials Business, sales of raw materials for cutting-edge EUV resists decreased in the semiconductor materials group, but sales of raw materials for ArF resists, which are the Company's mainstay, recovered, and Group-wide sales increased. In the display materials group, sales for insulating films for touch panels were strong, and sales for the group as a whole increased. In addition, sales of other groups were flat. As a result, net sales were 3,724 million yen (up 20.2% year on year) and segment profit was 530 million yen (up 202.6% year on year).
- Specialty Chemicals Business
In the Specialty Chemicals Business, sales were flat in the cosmetics materials group. In the functional materials group, sales remained solid. Sales of high-purity specialty solvents at subsidiaries remained strong. As a result, net sales were 1,476 million yen (up 16.8% year on year) and segment profit was 315 million yen (up 138.1% year on year).
2
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
(2) Financial Position for the Period under Review
Total assets at the end of the first quarter of the current fiscal year decreased by 5,497 million yen from the end of the previous fiscal year to 54,467 million yen. This was mainly attributable to a decrease of 2,921 million yen in cash and deposits, a decrease of 1,725 million yen in notes and accounts receivable-trade and contract assets, mainly due to the last day of the previous fiscal year being a holiday for financial institutions, a decrease of 221 million yen in finished goods, and a decrease of 281 million yen investment securities.
Liabilities at the end of the first quarter of the current fiscal year decreased by 3,360 million yen from the end of the previous fiscal year to 10,463 million yen. This was mainly due to a decrease of 1,714 million yen in notes and accounts payable - trade, mainly due to the last day of the previous fiscal year being a holiday for financial institutions, a decrease of 523 million yen in accounts payable - other, and a decrease of 407 million yen in income taxes payable.
Net assets at the end of the first quarter of the current fiscal year decreased by 2,136 million yen from the end of the previous fiscal year to 44,003 million yen. This was mainly due to an increase of 309 million yen in retained earnings, an increase of 2,224 million yen in treasury shares, and a decrease of 211 million yen in valuation difference on available-for-sale securities.
- Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements The consolidated financial results forecast announced on January 9, 2025, remain unchanged.
3
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
2. Quarterly Consolidated Financial Statements and Notes
(1) Quarterly Consolidated Balance Sheets
(Thousands of yen) | ||||
As of November 30, 2024 | As of February 28, 2025 | |||
Assets | ||||
Current assets | ||||
Cash and deposits | 13,047,614 | 10,126,298 | ||
Notes and accounts receivable - trade, and contract | 11,252,037 | 9,526,371 | ||
assets | ||||
Electronically recorded monetary claims - | 374,384 | 394,629 | ||
operating | ||||
Finished goods | 4,799,006 | 4,577,633 | ||
Work in process | 2,070,025 | 2,067,873 | ||
Raw materials and supplies | 1,989,293 | 1,982,533 | ||
Other | 773,069 | 777,723 | ||
Allowance for doubtful accounts | (18,415) | (14,176) | ||
Total current assets | 34,287,015 | 29,438,887 | ||
Non-current assets | ||||
Property, plant and equipment | ||||
Buildings and structures, net | 8,327,194 | 8,183,923 | ||
Machinery, equipment and vehicles, net | 7,530,545 | 7,319,999 | ||
Land | 2,172,476 | 2,172,476 | ||
Construction in progress | 94,679 | 38,330 | ||
Other, net | 290,291 | 317,537 | ||
Total property, plant and equipment | 18,415,187 | 18,032,266 | ||
Intangible assets | ||||
Goodwill | 23,333 | 18,333 | ||
Other | 50,538 | 46,700 | ||
Total intangible assets | 73,871 | 65,033 | ||
Investments and other assets | ||||
Investment securities | 6,294,854 | 6,013,701 | ||
Retirement benefit asset | 758,144 | 766,761 | ||
Deferred tax assets | 1,927 | 1,496 | ||
Other | 133,712 | 148,955 | ||
Total investments and other assets | 7,188,638 | 6,930,915 | ||
Total non-current assets | 25,677,697 | 25,028,215 | ||
Total assets | 59,964,713 | 54,467,103 | ||
4
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
(Thousands of yen) | ||||
As of November 30, 2024 | As of February 28, 2025 | |||
Liabilities | ||||
Current liabilities | ||||
Notes and accounts payable - trade | 5,924,864 | 4,210,272 | ||
Current portion of long-term borrowings | 2,188,610 | 2,104,453 | ||
Accounts payable - other | 1,524,265 | 1,000,978 | ||
Income taxes payable | 895,161 | 487,951 | ||
Provision for bonuses | - | 263,716 | ||
Provision for bonuses for directors (and other | 42,210 | 8,805 | ||
officers) | ||||
Other | 1,154,766 | 600,754 | ||
Total current liabilities | 11,729,879 | 8,676,931 | ||
Non-current liabilities | ||||
Long-term borrowings | 1,337,923 | 1,200,459 | ||
Deferred tax liabilities | 634,911 | 472,849 | ||
Provision for share awards for directors (and other | 35,086 | - | ||
officers) | ||||
Other | 86,937 | 113,522 | ||
Total non-current liabilities | 2,094,858 | 1,786,831 | ||
Total liabilities | 13,824,737 | 10,463,763 | ||
Net assets | ||||
Shareholders' equity | ||||
Share capital | 3,600,295 | 3,600,295 | ||
Capital surplus | 3,513,436 | 3,513,443 | ||
Retained earnings | 38,727,951 | 39,037,663 | ||
Treasury shares | (3,129,535) | (5,353,564) | ||
Total shareholders' equity | 42,712,148 | 40,797,837 | ||
Accumulated other comprehensive income | ||||
Valuation difference on available-for-sale | 2,344,090 | 2,132,130 | ||
securities | ||||
Foreign currency translation adjustment | 132,235 | 99,458 | ||
Remeasurements of defined benefit plans | 246,812 | 244,313 | ||
Total accumulated other comprehensive income | 2,723,138 | 2,475,902 | ||
Non-controlling interests | 704,689 | 729,599 | ||
Total net assets | 46,139,976 | 44,003,339 | ||
Total liabilities and net assets | 59,964,713 | 54,467,103 |
5
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
-
Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statements of Income (For the three months)
(Thousands of yen) | ||
For the three months | For the three months | |
ended February 29, 2024 | ended February 28, 2025 | |
Net sales | 7,066,021 | 8,516,926 |
Cost of sales | 5,282,984 | 5,846,560 |
Gross profit | 1,783,036 | 2,670,366 |
Selling, general and administrative expenses | 1,202,420 | 1,304,495 |
Operating profit | 580,615 | 1,365,870 |
Non-operating income | ||
Interest income | 601 | 2,771 |
Dividend income | 33,947 | 36,842 |
Foreign exchange gains | 17,549 | - |
Insurance claim income | - | 97,183 |
Other | 11,105 | 28,683 |
Total non-operating income | 63,203 | 165,480 |
Non-operating expenses | ||
Interest expenses | 2,314 | 2,406 |
Foreign exchange losses | - | 45,193 |
Commission for purchase of treasury shares | 602 | 2,400 |
Loss on investments in investment partnerships | 591 | 506 |
Other | - | 0 |
Total non-operating expenses | 3,508 | 50,507 |
Ordinary profit | 640,311 | 1,480,843 |
Extraordinary income | ||
Gain on sale of investment securities | 273,751 | - |
Total extraordinary income | 273,751 | - |
Extraordinary losses | ||
Loss on retirement of non-current assets | 102 | 199 |
Total extraordinary losses | 102 | 199 |
Profit before income taxes | 913,960 | 1,480,644 |
Income taxes - current | 409,192 | 466,937 |
Income taxes - deferred | (116,318) | (68,048) |
Total income taxes | 292,873 | 398,888 |
Profit | 621,086 | 1,081,755 |
Profit attributable to non-controlling interests | 17,675 | 46,306 |
Profit attributable to owners of parent | 603,410 | 1,035,449 |
6
OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25
Quarterly Consolidated Statements of Comprehensive Income (For the three months)
(Thousands of yen) | |||
For the three months | For the three months | ||
ended February 29, 2024 | ended February 28, 2025 | ||
Profit | 621,086 | 1,081,755 | |
Other comprehensive income | |||
Valuation difference on available-for-sale securities | 526,368 | (211,286) | |
Foreign currency translation adjustment | 14,415 | (32,776) | |
Remeasurements of defined benefit plans, net of tax | 2,224 | (2,559) | |
Total other comprehensive income | 543,008 | (246,623) | |
Comprehensive income | 1,164,094 | 835,132 | |
Comprehensive income attributable to | |||
Comprehensive income attributable to owners of | 1,145,212 | 788,214 | |
parent | |||
Comprehensive income attributable to non-controlling | 18,881 | 46,917 | |
interests | |||
7
